Intercept to Present at Upcoming Investor Conferences
- Cowen 39th Annual Healthcare Conference at
8:00 a.m. ETon Tuesday, March 12, 2019
- Oppenheimer 29th Annual Healthcare Conference at
11:30 a.m. ETon Tuesday, March 19, 2019
Webcast information for these events will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept’s website for approximately two weeks.
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in
For more information about Intercept, please contact:
Media inquiries: email@example.com
Source: Intercept Pharmaceuticals, Inc.